Effect of anticancer agents on cell cycle of regenerating hepatocytes in rats. 1992

J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
1st Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

The effect of three anticancer agents, cisplatin, doxorubicin, and mitomycin, on liver regeneration after 70% partial hepatectomy in rats was investigated by total DNA content of the liver and flow cytometric analysis of hepatocyte nuclei using two-color staining of anti-bromodeoxyuridine monoclonal antibody and propidium iodide. Total DNA content of regenerating liver 7 days after hepatectomy showed significant suppression of regeneration by these agents (P less than 0.01). The inhibitory effects of the agents on the cell cycle of hepatocytes by flow cytometric analysis were (1) a delay of the peak or a decrease in the proportion of S phase nuclei and/or (2) polyploidization of the nuclei, demonstrated by accumulation of 8c and occasionally 16c nuclei, of which the DNA contents were four and eight times as much as that of diploid (2c) cell nuclei, respectively. The former (1) suggests G0 or G1 phase block, and the latter (2) G2 phase block. In terms of total DNA content of regenerating liver, the inhibitory effect was most prominent in the cisplatin-administered groups. The polyploidization of nuclei was most remarkable in the mitomycin-administered groups. Although the total DNA content recovered to the level of control at 6 weeks after hepatectomy, the polyploidization effect persisted in the drug-administered groups. These agents had no cytocidal action on proliferating hepatocytes as can be seen from the aspartate aminotransferase and alanine aminotransferase serum levels. We conclude that in a short-term observation, the anti-cancer agents significantly inhibit liver regeneration, although the inhibitory effect on DNA synthesis does not last long.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008115 Liver Regeneration Repair or renewal of hepatic tissue. Liver Regenerations,Regeneration, Liver,Regenerations, Liver
D008297 Male Males
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum

Related Publications

J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
January 1978, Antibiotics and chemotherapy,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
April 1971, Biulleten' eksperimental'noi biologii i meditsiny,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
March 2005, Current cancer drug targets,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
December 1984, Kokyu to junkan. Respiration & circulation,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
January 2005, Anticancer research,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
January 1981, The American journal of Chinese medicine,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
January 1981, Voprosy meditsinskoi khimii,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
July 2002, Current medicinal chemistry. Anti-cancer agents,
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
January 2004, Cell cycle (Georgetown, Tex.),
J Tamura, and J Tanaka, and K Fujita, and M Yoshida, and T Kasamatsu, and S Arii, and T Tobe
January 2024, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!